Clinical Trial Update: Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SPARC1316 [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update summarizes safety, tolerability, pharmacokinetic and pharmacodynamic data for SPARC1316 in Phase 1/2 asthma studies, with results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• SPARC1316

Snippet

Sponsor: Sun Pharma Advanced Research Company Limited | Conditions: Asthma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2016-03-31